Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regulus Therapeutics Inc (NASDAQ:RGLS)

5.84
Delayed Data
As of Apr 29
 -0.32 / -5.19%
Today’s Change
5.14
Today|||52-Week Range
14.50
-33.03%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues4.2M3.8M1.9M10.9M
 
 
 
 
 
Depreciation And Amortization394.0K404.0K379.0K414.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses16.7M24.6M14.8M17.8M
 
 
 
 
 
Research And Development13.4M19.2M11.0M12.8M
 
 
 
 
 
Total Operating Expenses17.1M25.0M15.2M18.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.9M-21.2M-13.3M-7.4M
 
 
 
 
 
Extraordinary Charge-1.8M0.000.00--
 
 
Interest Expense On Debt8.0K7.0K6.0K30.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-14.5M-21.0M-13.0M-7.2M
 
 
 
 
 
Income Taxes-4.0K-2.0K-16.0K-4.0K
 
 
 
 
 
Net Income-14.5M-21.0M-13.0M-7.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS50.1M51.1M52.0M52.5M
 
 
 
 
 
Shares To Calculate EPS Diluted50.1M51.1M52.0M52.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.29-$0.41-$0.25-$0.14
 
 
 
 
 
EPS Diluted-$0.29-$0.41-$0.25-$0.14